A variety of chemicals induce site-specific lesions in the rodent nasal cavity. In order to explore the reasons for this site-selectivity, methodology for (a) creation of a 3-dimensional (3D) model of a rat nasal cavity, and (b) mapping of semiquantitative data onto the model has been developed. The head of a rat was fixed, decalcified, step-sectioned (every 100 µm) and stained with hematoxylin and eosin. Digital images of the sections were optically captured, and a KS400 image analysis system (Imaging Associates, Thame, Oxford, UK), attached to a standard personal computer, was used to align adjacent images and reconstruct the series in 3D. The final model was anatomically correct, and could be rotated in any plane and manipulated to display individual internal structures. The spatial localization of a glutathione S-transferase (rGSTM1, previously known as GST 3-3) within this model was investigated using immunohistochemistry.
INTRODUCTION
Over recent years there has been a burgeoning interest in the nasal cavity, both as the site of olfaction and as a target for the toxicity induced by a wide variety of drugs (12, 14) , herbicides (6, 24) and industrial chemicals (10, 15, 23, 28) . The structure of the nasal cavity is relatively simple in humans, but is extremely complex in rodents and other animals that rely heavily on their sense of smell (11) . Essentially the nasal cavity is a chamber that is divided into 2 compartments by the nasal septum, and into which project scroll-shaped, cartilaginous turbinates (32) . These structures increase the surface area of the nasal epithelia and divide the major inspiratory air streams, thus aiding both the air conditioning and olfactory functions of the nasal cavity. However, the complexity of the rodent nasal cavity is a hindrance when attempting to understand relationships between structure and function from either a physiological or toxicological viewpoint. Thus there have been a number of attempts to model, in 3 dimensions, the nasal passages of several species (16-20, 25, 26, 29) .
Early studies used hollow molds of the airways of the nasal cavity in order to elucidate inspiratory airflow patterns, and allow prediction of the regional deposition of inhaled chemicals within the nose (18, 25, 26) . Later, Kimbell and coworkers (19, 20) used histological techniques to generate 2-dimensional (2D) geometrical data that were subsequently used to construct a 3-dimensional (3D) computational model of the F344 rat nasal cavity. The resultant model was a 3D wire-frame grid of the rat nasal passages, which consisted of thousands of nodes joined together with line-vectors. This work was later extended to include the rhesus monkey and human nasal passages (17, 29) . Recently, Bush et al (7) incorporated the model of the F344 rat nasal cavity into a physiologically based pharmacokinetic model of the tissue, thus allowing simulation of gas and vapour uptake in the nose. These models were all instrumental in identifying the major airstreams within the nasal cavity, and in predicting the dosimetry of inhaled compounds within the nasal passages. However, they are of limited use because (a) the complexity of the mathematical computations limits their use on standard PCs, (b) the computer packages used do not facilitate visualization of the internal structures of the nose, and (c) quantitative data regarding the localization of enzymes and receptors cannot easily be overlaid on the models.
Our laboratories have an ongoing interest in the role of bioactivation in the development of site-specific lesions within the nasal cavity. In order to increase our knowledge in this area we wished to be able to explore, in 3D, the relationships between the regional deposition of selected chemicals, the distribution of the lesions induced by these toxins, and the regional distribution of the relevant biotransformation enzymes. As the first step in this process, the aims of this work were (a) to develop a 3D model of a rat nasal cavity that would allow incorporation of semiquantitative data on enzyme and lesion distribution, and (b) map the 3D distribution of a glutathione S-transferase (rGSTM1, previously known as GST 3-3), an enzyme whose 2D distribution we have documented previously (1) .
METHODS

Tissue Preparation
Two male Alpk:AP f SD Wistar rats (6-8 weeks old) were obtained from the Rodent Breeding Unit, AstraZeneca, Alderley Park, Macclesfield, UK. The rats were sacrificed by exsanguination via cardiac puncture under halothane anesthesia, decapitated, and the brain, lower jaw, and surrounding connective tissue removed. The nasal passages were perfused through the nasopharynx with approximately 10 ml of 10% neutral buffered formalin and then immersed in the same fixative for 48 hours. At the end of the fixation period, heads were decalcified in neutral buffered, saturated EDTA for 30 days, with the decalcification fluid being changed every other day. The heads were then sliced transversely into 2 halves immediately anterior to the first upper molar, were oriented by laying the cut surfaces down, and were processed through to paraffin wax.
Step sections (each 5 µm thick) were cut and stained with hematoxylin and eosin (H & E) or by immunohistochemistry. For generation of the 3D model, 1 section was cut every 100 µm and a total of 108 sections was used. For localization of rGSTM1, 2 duplicate sections were cut every 400 µm.
Immunohistochemistry (IHC)
For localization of rGSTM1, the duplicate sections were dewaxed in xylene, rehydrated in a graded series of alcohols and endogenous peroxidase activity blocked by immersing the sections in 3% hydrogen peroxide in methanol for 20 minutes. After washing in water, sections were incubated at 37 • C in normal swine serum (DAKO Ltd, Cambridge, UK) (1/50 dilution in 0.05 M Tris-HCl, pH 7.6) for 30 minutes. Sections were then incubated at 4 • C in rabbit anti-rGSTM1 (Biotrin Ltd, Dublin, Eire)(1/200 dilution in 0.05 M Tris-HCl, pH 7.6) for 24 hours. After washing (3 × 5 minutes) in 0.05 M Tris-HCl, pH 7.6, sections were treated with biotinylated swine anti-rabbit immunoglobulins (DAKO Ltd, Cambridge, UK)(1/200 dilution in 0.05 M Tris-HCl, pH 7.6) for 1 hour at 37 • C. Sections were then washed as above, 200 µl streptavidin-biotin horseradish peroxidase complex (DAKO Ltd, Cambridge, UK) added for 20 minutes at room temperature, and after a final wash, developed using diaminobenzidine tetrahydro-chloride (Sigma-Aldrich Company Ltd, Poole, UK). Control sections were stained as described previously, with the omission of either the primary or secondary antibodies, or the streptavidin-biotin horseradish peroxidase complex. No staining was observed on these sections. For localization of rGSTM1, sections were counterstained in hematoxylin; for imaging densitometry, the sections were not counterstained. Sections were then dehydrated in alcohol, cleared in xylene, and mounted in DPX.
Imaging Densitometry
Two-dimensional maps of the nasal sections were demarcated into regions of approximately equal length, and each region assigned 2 equidistant points for densitometric analysis ( Figure 1 ). The regions were not based upon epithelial type, and a single region may contain more than 1 type of epithelium. The epithelium at each point was viewed by light microscopy (final magnification × 160) and then converted to a digital image using a monochrome digital video camera (Sony XC-77CE). The average staining intensity of the epithelium was determined at each point on each of the duplicate sections using the KS400 image analysis system (Imaging Associates, Thame, UK), and expressed as the grey value/µm 2 . The values were plotted on a frequency histogram (results not shown), and the data divided into 4 groups at the median and the first and third quartiles. Each group represented a level of staining intensity that was assigned a color: high, red; medium to high, yellow; medium to low, green; and low, blue.
Creation of a 3D Model of a Rat Nasal Cavity
Each of the H&E-stained sections was placed on a light box and a digital image captured using a monochrome digital camera (Sony XC-77CE) fitted with a monovar low magnification lens and connected to the KS400 image analysis system (Figure 2a ). The digitized sections were then aligned in the x-and y-planes as follows: The KS400 image analysis system displayed the image of 1 section in red, and that of the adjacent section in blue ( Figure 2b ). The 2 images were then superimposed, and the second could be rotated and/or shifted until the 2 sections were aligned along the nasal septum. This process was repeated until all the sections had been aligned. The image sequence was then played as a rapidly moving 2D animation, in order to check the alignment of the sections. TOXICOLOGIC PATHOLOGY FIGURE 2.-Creation of a 3D-model of a rat nasal cavity. Nasal sections stained with H&E were captured as monochrome digital images (a). The images were then aligned sequentially (b). The KS400 image analysis system displays a reference section in red and the adjacent section (displayed in blue) can then be shifted until the 2 are aligned. Aligned images were then converted to binary images (c).
In order to focus on the airways, all the images were then converted to binary images, with the airways white and the tissue black ( Figure 2c ). Finally the images were stacked, each being expanded in the z-plane by 100 µm (the distance between the histological sections), to give a 3D reconstruction of the airways.
Incorporation of IHC Data
As the sections stained for rGSTM1 were cut every 400 µm, while those for the model were cut every 100 µm, the imaging densitometry data was superimposed onto every fourth section of the model. Each of the 4 colors was individually digitally 'painted' onto the model sections, thus creating 4 separate sequences. All of the uncolored structures were then removed from these sequences which were saved as a red, yellow, green, or blue sequence ( Figure 3 shows the procedure, but utilizes grey rather than 1 of the 4 colors). The colored sequences, together with the complete 3D model, were then all reconstructed in the same phase space at the same time, with the z-planes of the colored images being expanded by 400 µm.
Controls for the IHC Image Analysis Protocol
The relationship between rGSTM1 staining intensity and section thickness was investigated, and found to remain relatively constant for sections of 5-7 µm. Thus, care was taken to ensure that sections were cut within this range. Because of the known relationship between staining intensity and the intensity of the microscope illumination, the microscope illumination was maintained at a constant level. In order to avoid variations in the IHC process, all sections were stained at the same time, and under identical conditions. Furthermore, the head of a second rat was used to cut serial sections from an area where the anatomical variation, and thus hopefully GST expression, between the sections would be minimal [level 5 as described by Mery et al (22) ]. These sections were placed on the slides containing the step sections and stained alongside them. Imaging densitometry of these sections demonstrated no significant changes in rGSTM1 staining intensity, confirming that the differences seen in the step sections were real, and not artefacts due to differences in the methodology. Thus we are confident that the localization of rGSTM1 shown in Figure 8 is a true reflection of the pattern of expression of this enzyme.
RESULTS
The 3D-Model of a Rat Nasal Cavity Figure 4 shows the final 3D-model of the nasal cavity of a rat. In this model, the airways are solid structures and the turbinates appear as invaginations in the airways. At the anterior end of the model, the naso-and maxillo turbinates, the septum and the incisive ducts can all be seen. At the posterior of the model is the nasopharyngeal duct, and the regions in which the dorsal meatus and ethmoturbinates are situated are also apparent. As this is a solid model of the airways, viewed from the outside, the individual ethmoturbinates are not visible. However, the KS400 image analysis system allows the final 3D-model to be rotated in either the x-, y-, or z-plane, and distinct anatomical structures can be dissected out and visualised as individual structures. Thus the model can be sectioned and the septum removed to produce a saggital view of the nasal cavity ( Figure 5a ). In this view, the naso-, maxillo, and ethmoturbinates are all clearly visible, and the model is remarkably similar to a saggital section through a rat head (Figure 5b ).
Immunohistochemical Localization of rGSTM1
Within the nasal epithelia, IHC staining for rGSTM1 was virtually absent in squamous epithelium and was observed only in occasional cells within the transitional epithelium. Staining within respiratory epithelium was variable. rGSTM1 appeared to be expressed predominantly within pseudostrat- ified columnar cells, so areas with a high goblet cell density showed very little immunoreactivity, whereas areas lacking these cells stained more intensely (Figures 6a and b) . In olfactory epithelium, the sustentacular cells and basal cells stained for rGSTM1, whereas the neurons did not appear to express this enzyme (Figure 6c ).
The intensity of the staining within the nasal cavity was determined by imaging densitometry, and a color assigned to each level of staining intensity (high, red; medium to high, yellow; medium to low, green; low, blue) as described in the Methods section. This data was then incorporated into 2Dmaps of the nasal cavity, prior to superimposing it onto the 3D-model. Figure 7 shows the localization of rGSTM1 within 6 levels of the nasal cavity that correspond to levels 5, 7, 10, 17, 23, and 28 described by Mery et al (22) . It can be seen that the staining is low in the anterior of the cavity, increases to reach a maximum at levels 2 and 3, and then decreases again in the posterior of the cavity. The region of maximal staining corresponds to an area of the nasal cavity that lies between the second and fourth palatal ridges. 
Incorporation of IHC Data onto the 3D Model
Reconstruction of the whole nasal cavity, or parts thereof, with the data showing the distribution of rGSTM1 superimposed are shown in Figure 8 . When trying to depict a 3D structure in 2D, it is inevitable that there will be regions where different structures overlay one another. For example, in a lateral view of the nasal cavity the lateral walls, turbinates, and septum are superimposed. If these regions are represented by more than one color, the imaging software colors them black (Figure 8b ). This is a limitation of the methodology, but when individual structures such as the nasal septum are dissected out (Figure 8c ) this is no longer an issue. The trend described previously, with staining intensity being maximal in the central regions of the nasal cavity, is apparent and the greatest expression of rGSTM1 appears to be in the epithelia immediately anterior to the ethmoturbinates, and covering the anterior tips of these structures.
DISCUSSION
The current 3D-model of a rat nasal cavity was created using stepped histological sections cut and then stained with H&E. An alternative method that was evaluated was that of Kepler et al (16) who mounted the head of a Rhesus monkey in a cryostat, and photographed the cutting face after each section had been cut, thus obtaining a series of 2D-images of the nasal cavity. The production of consistently high quality frozen sections of undecalcified heads in which the structural integrity and morphology of the tissues are preserved presents considerable technical difficulties. However, Kepler et al (16) circumvented this problem by capturing images of the remaining surface of the head block rather than the sections that had been cut from the block. That method is dependent upon the natural density differences inherent in the tissue within the block to distinguish the separate tissues of the nasal cavity. As a result, the resultant resolution was low and only gross tissue differences are discernible. Subramaniam et al (29) used magnetic resonance imaging to generate a series of 2D-sections of the human nose. However, once again the level of resolution obtainable was low.
In the current methodology, the distance between adjacent sections was small enough to create a model with good resolution and that included all the important nasal structures. Smaller steps would have resulted in minimal improvement in the accuracy of the model and would have significantly increased the number of sections that had to be analyzed. In the model, the tips of ethmoturbinate 3 are missing (Figure 5a compared to Figure 5b ). When the whole head was sectioned transversely into 2 halves, the tips of these turbinates were located in the anterior half. They were thus islands of tissue within the airways, unconnected to any supporting structures, and were lost during subsequent processing and sectioning. Similarly, the tip of the nose is missing (Figure 5a compared to Figure 5b ) because it was removed before embedding the nasal cavity in wax. The KS400 imaging system proved to be an extremely powerful and versatile software package for 3D-modelling. Both the nasal tissue and the airways can be modelled, depending on the outcome required. For modelling the whole nasal cavity, we chose to reconstruct the airways as this allowed visualisation of some aspects of the internal structure of the cavity, rather than merely the outside of the head. When investigation of individual turbinates was required, the tissue was reconstructed. In either case, the final model can be rotated in either the x, y, or z-plane and thus viewed from any angle, and this can be achieved with a personal computer. Furthermore, the incorporation of semiquantitative data proved a relatively simple process. Vol. 31, No. 3, 2003 3D MODELLING OF RAT NASAL GSTM1 337 FIGURE 7 .-The distribution of rGSTM1 at levels 1-6 of the rat nasal cavity. Levels 1-6 correspond to levels 5, 7, 10, 17, 23, and 28 as described by Mery et al (22) . Colors represent levels of immunohistochemical staining intensity; Red = high; yellow = medium to high; green = medium to low; blue = low. rGSTM1 was chosen as the enzyme for the development of techniques for superimposition of immunohistochemical data onto the 3D-model because (a) the GSTs are an important family of biotransformation enzymes that have been extensively characterised within the nasal cavity (1, 2) , and (b) rGSTM1 is one of the major olfactory GSTs (2) and its localization at 4 levels of the nasal cavity has previously been reported (1) . rGSTM1 was found to be expressed within the pseudostratified columnar cells of respiratory epithelium, and the sustentacular and basal cells of olfactory epithelium in agreement with previous reports (1) . When visualised in 3D, it was clear that the highest staining for rGSTM1 was in the central regions of the nasal cavity, in an area that represents a transition between the respiratory and olfactory zones and that includes the tips of the ethmoturbinates. Biochemical analysis of nasal enzyme activity commonly involves dissection of whole naso-, maxillo-, and ethmoturbinates, and tissue homogenisation (27) .
In such studies, the activity of this high-staining region is likely to be overlooked because it includes tissue that would not normally be investigated (that lining the lateral walls) or would be homogenised with other epithelia (those lining the septum and turbinates). According to the dosimetry predictions of Kimbell and coworkers (19, 21) this region of the nasal cavity is not exposed to particularly high concentrations of inspired chemicals, thus the high expression may not merely be a response to a requirement for conjugation or to exposure to environmental inducing agents. At present, it is 338 ROBINSON ET AL TOXICOLOGIC PATHOLOGY not known whether other drug metabolising enzymes show a similar pattern of expression, and until this becomes clear it is difficult to speculate on the physiological/toxicological reasons for the high levels of rGSTM1 in this area.
There are limitations to the approach taken in this study. First, only staining within the epithelium was quantitated, the subepithelium was not considered. There were 2 main reasons for this; the epithelium is a major target for many of the chemicals that damage the nasal tissues (3, 9, 10, 13, 15, 28, 31, 34) , and the enzymes we propose to study in future are predominantly localised within the epithelium (1, 8, 27, 30) . It is well known however, that many nasal drug metabolising enzymes are also expressed in the underlying glands of the lamina propria (4, 5, 8, 27, 30, 33) , and that the regional susceptibility of different areas of the nasal cavity may be influenced by levels of enzyme expression in these cells. Second, in order to reduce the analysis to manageable proportions, only certain points within each section were analyzed. At these points, imaging densitometry calculated an average staining intensity for an area of epithelium as a whole rather than for individual cells. Hence, individual cells that may have had high enzyme expression lying within a majority expressing low levels would have been given a low score. Finally, IHC demonstrates the presence of enzyme protein, but gives no indication of whether or not that protein is catalytically active. However, for the majority of enzymes IHC is the only method available for their localization within tissue sections. All these considerations need to be taken into account when interpreting the results.
The methodology that we have developed is undeniably labour-intensive and would not be appropriate for routine nasal pathology. Our ultimate aim is to be able to compare the localisation of bioactivating enzymes and the distribution of lesions with the regional deposition of inhaled toxins within the nasal cavity. Airflow and dosimetry can only be reconstructed in 3 dimensions, thus it was necessary to develop methodology to enable the other parameters to be modelled in 3D. It is envisaged that this methodology would have applications in understanding the mode of action of toxic chemicals and also in the prediction of potential nasal toxicity in rodents.
In summary, we have developed a 3D-model of a rat nasal cavity that bears a striking resemblance to its natural counterpart, and we have been able to map the localization of 1 drug metabolising enzyme on this model. In order to explore the relationships between bioactivation and the site-specificity of lesions within the nasal cavity, this work is currently being extended to include mapping of (a) other enzymes, and (b) the lesions resulting from exposure to chemicals activated by those enzymes.
